BlackRock Investment Management, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 74 filers reported holding SAGE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$6,662,000
+11.0%
130,472
+0.1%
0.01%
+14.3%
Q3 2016$6,002,000
+80.9%
130,334
+18.4%
0.01%
+75.0%
Q2 2016$3,317,000
+67.5%
110,084
+78.3%
0.00%
+33.3%
Q1 2016$1,980,000
-36.7%
61,752
+15.2%
0.00%
-25.0%
Q4 2015$3,126,000
+37.6%
53,624
-0.1%
0.00%
+33.3%
Q3 2015$2,271,000
-46.0%
53,671
-6.9%
0.00%
-40.0%
Q2 2015$4,207,000
+338.2%
57,631
+201.6%
0.01%
+400.0%
Q1 2015$960,000
+40.6%
19,110
+2.4%
0.00%0.0%
Q4 2014$683,000
+24.2%
18,663
+6.9%
0.00%0.0%
Q3 2014$550,00017,4600.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders